Diker Mark N. 4
4 · CANTEL MEDICAL CORP · Filed Jan 22, 2020
Insider Transaction Report
Form 4
Diker Mark N.
Director
Transactions
- Purchase
Common Stock, par value $.10 per share
2020-01-17$62.43/sh+1,000$62,433→ 426,233 total - Purchase
Cantel Medical Corp.
2020-01-17$62.42/sh+1,000$62,420→ 1,000 total(indirect: By Spouse)
Holdings
- 48,544(indirect: By Children)
Common Stock, par value $.10 per share
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $61.94 to $62.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff the issuer or a security holder of the issuer information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $61.85 to $62.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff the issuer or a security holder of the issuer information regarding the number of shares and prices at which the transaction was effected.